Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission (vol 62, pg 765, 2012)

被引：0
|
作者：
Tanahashi, Shunsuke [1 ]
Yamamura, Satoshi [1 ]
Nakagawa, Masanori [1 ]
Motomura, Eishi [1 ]
Okada, Motohiro [1 ]
机构：
[1] Mie Univ, Brain Sci & Anim Model Ctr BSAM, Grad Sch Med, Dept Psychiat, 2-174 Edobashi, Tsu, Mie 5148507, Japan
来源：
NEUROPHARMACOLOGY | 2019年 / 148卷
关键词：
D O I：
10.1016/j.neuropharm.2018.11.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [1] Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission
    Tanahashi, Shunsuke
    Yamamura, Satoshi
    Nakagawa, Masanori
    Motomura, Eishi
    Okada, Motohiro
    NEUROPHARMACOLOGY, 2012, 62 (02) : 765 - 774
  • [2] The dopamine-serotonin system stabilizer aripiprazole is a partial agonist at D2 and 5-HT1A receptors
    Jordan, S
    Robert, MD
    Frank, YD
    Tetsuro, K
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 183S - 183S
  • [3] Dopamine D2 and serotonin 5-HT1A receptors of the brain in processing of pain
    Pertovaara, A.
    Martikainen, I. K.
    Hagelberg, N.
    Hirvonen, J.
    Scheinin, H.
    Hietala, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S113 - S113
  • [4] The antipsychotic aripiprazole induces antinociceptive effects: Possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors
    Almeida-Santos, Ana F.
    Ferreira, Renata C. M.
    Duarte, Igor D.
    Aguiar, Daniele C.
    Romero, Thiago R. L.
    Moreira, Fabricio A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 300 - 306
  • [5] Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors
    Clinckers, R
    Smolders, I
    Meurs, A
    Ebinger, G
    Michotte, Y
    JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) : 834 - 843
  • [6] Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
    Glennon, RA
    Dukat, M
    Grella, B
    Hong, SS
    Costantino, L
    Teitler, M
    Smith, C
    Egan, C
    Davis, K
    Mattson, MV
    DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) : 121 - 132
  • [7] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors
    A. Newman-Tancredi
    D. Cussac
    V. Audinot
    M. J. Millan
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 447 - 453
  • [8] Reversal of phencyclidine stimulated basolateral amygdala dopamine and noradrenaline release by aripiprazole but not clozapine, ziprasidone and haloperidol involves dopamine D2 and serotonin 5-HT1A receptors
    Glennon, J
    Lewis, L
    Van de Kooij, M
    McCreary, AC
    Hamelink, R
    Leguit, N
    Tros, R
    Kleefstra, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S518 - S519
  • [9] Serotonin 5-HT1A and 5-HT2A receptors in frontal cortex mediate actions of risperidone in juvenile animals
    Gardy, C
    Moran-Gates, T
    Baldessarini, RJ
    Tarazi, FI
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 59S - 59S
  • [10] Bifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptors
    Wadenberg, Marie-Louise G.
    FUTURE NEUROLOGY, 2007, 2 (02) : 153 - 165
12345